TSE:3591
TSE:3591Luxury

Wacoal Holdings (TSE:3591): Assessing Valuation After Earnings Forecast Revision and U.S. Sales Challenges

Wacoal Holdings (TSE:3591) has updated its consolidated earnings forecast for the second quarter, pointing to a 9% drop in revenue as sluggish sales in major markets continue, including softness in women’s innerwear and persistent challenges in the U.S. retail landscape. The company’s full-year outlook is now under review, raising questions about the path forward for this established name in apparel. See our latest analysis for Wacoal Holdings. Wacoal’s shares have seen modest gains over the...
TSE:7276
TSE:7276Auto Components

Koito Manufacturing (TSE:7276) Net Margin Surge Driven by ¥16.2B One-Off Gain Spurs Sustainability Debate

Koito Manufacturing (TSE:7276) delivered a net profit margin of 5.4%, up from 3.5% last year, and grew earnings by 46.1% year over year. This far outpaces its five-year average of 0.4% per year, driven in part by a one-off gain of ¥16.2 billion. Despite this surge, revenue is forecast to rise at just 3% per year compared to the broader Japanese market's 4.5% annual pace, with shares currently trading at ¥2,337, above an estimated fair value of ¥1,594.9. Investors are weighing the improved...
TSE:4528
TSE:4528Pharmaceuticals

Ono Pharmaceutical (TSE:4528): Assessing Valuation Following New Phase 3 Data on Vimseltinib in TGCT

Ono Pharmaceutical (TSE:4528) is in the spotlight after sharing two-year results from its MOTION Phase 3 study of vimseltinib in TGCT patients at the ESMO Congress. The company highlighted new data on efficacy and safety. See our latest analysis for Ono Pharmaceutical. Fresh trial results appear to have caught investors’ attention, with Ono Pharmaceutical’s share price climbing over 10% in the past month and more than 14% over the last 90 days. While this momentum signals renewed optimism, it...
TSE:6857
TSE:6857Semiconductor

Advantest (TSE:6857) Margin Surge Reinforces Bull Case, But Valuation Premium Faces Scrutiny

Advantest (TSE:6857) reported net profit margins of 26.8%, up from last year’s 17.7%, driven by significant profit growth. EPS surged 147.5% this year, topping the already-strong five-year annual earnings growth rate of 21.9%. Revenue and earnings are forecast to outpace the Japanese market, giving investors plenty to consider as the company sustains its momentum with high-quality margins and robust growth projections. See our full analysis for Advantest. Next up, let’s see how these headline...